BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 649446)

  • 1. Sequential 5-fluorouracil and hydroxyurea therapy for metastatic colorectal adenocarcinoma.
    Krein BM; Conroy JF; Brodsky I
    J Am Osteopath Assoc; 1978 Apr; 77(8):604-5. PubMed ID: 649446
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma.
    Greco FA; Richardson RL; Shulman SF; Oldham RK
    Cancer Treat Rep; 1978 Sep; 62(9):1407-8. PubMed ID: 688289
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
    Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ
    Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Mar; 62(3):461-2. PubMed ID: 348317
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequential 5-fluorouracil, methotrexate, and calcium leucovorin in metastatic colorectal cancer.
    Hansen RM; Banerjee TK; Davis HL; Zaentz SD; Schiferl EA; Ousley JL; Pogodzinski AE; Trump DL
    Wis Med J; 1988 May; 87(5):20-3. PubMed ID: 3291405
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of a sequential 5-FU and hydroxyurea combination in advanced bowel cancer.
    Kao AK; Muggia FM; Dubin N; Lerner WA; Stark R; Wernz JC; Speyer JL; Blum RH
    Cancer Treat Rep; 1984 Nov; 68(11):1383-5. PubMed ID: 6498854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy of colorectal carcinomas].
    Hartwich G; Neidhardt B
    Dtsch Med Wochenschr; 1978 Sep; 103(38):1463-5. PubMed ID: 80315
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II study of ftorafur in previously untreated and treated patients with advanced colorectal cancer.
    Schutt AJ; Hahn RG; Moertel CG; O'Connell MJ; Rubin J; Creagan ET
    Cancer Treat Rep; 1983 May; 67(5):505-6. PubMed ID: 6406062
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II study of melphalan in colorectal carcinoma.
    DiBenedetto J; Moayeri H; Evans JT; Mittelman A
    Cancer Treat Rep; 1978 Sep; 62(9):1401-2. PubMed ID: 688286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic colorectal carcinoma. Response to hepatic infusion. A review.
    Donegan WL; Harris HS
    Mo Med; 1970 Mar; 67(3):163-8. PubMed ID: 4190052
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer.
    Cantrell JE; Brunet R; Lagarde C; Schein PS; Smith FP
    Cancer Treat Rep; 1982 Jul; 66(7):1563-5. PubMed ID: 7093972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined 5-fluorouracil and hydroxyurea therapy for gastrointestinal cancer.
    Lokich JJ; Pitman SW; Skarin AT
    Oncology; 1975; 32(1):34-7. PubMed ID: 1208028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of treatment with 5-fluorouracil and folinic acid in patients with carcinoma of the large intestine].
    Nastasi G; Sala L; Romano AM; Nucera D; Anselmetti L; Castoldi O; Crema F; Pasotti D
    Medicina (Firenze); 1988; 8(2):175-8. PubMed ID: 2852292
    [No Abstract]   [Full Text] [Related]  

  • 14. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
    Cedermark BJ; Didolkar MS; Elias EG
    Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of metastatic colorectal carcinoma with cisplatin and 5-FU.
    Shepard KV; Faintuch J; Bitran JD; Sweet DL; Robin E; Levin B
    Cancer Treat Rep; 1985 Jan; 69(1):123-4. PubMed ID: 4038471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
    Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
    Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiblastic therapy of nonadvanced colorectal cancer: preliminary results of a randomized therapeutic trial].
    Bertoldi I; Barzi A; Cavaleri V; D'Avena C; De Vecchis L; Mangialardi N; Chirletti P
    Ann Ital Chir; 1982; 54(1):77-85. PubMed ID: 6756248
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II study of cyclophosphamide and cytarabine in the treatment of metastatic adenocarcinoma of the colon and rectum.
    Denefrio JM; Kaplan RS; Eisenberger MA; Lessner HE
    Cancer Treat Rep; 1981; 65(1-2):163-4. PubMed ID: 7226166
    [No Abstract]   [Full Text] [Related]  

  • 19. [The possibilities of drug therapy in metastazing carcinoma of the large intestine].
    Neubauer HW
    Schweiz Med Wochenschr; 1967 May; 97(18):590-2. PubMed ID: 5585958
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.